Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Lunai Bioworks Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −4 vs. Q1 2021
- Shares held
- 2.67M
- −43.9K (−1.6%) vs. Q1 2021
- Total value
- $13.3M
- +$3.67M (+38.2%) vs. Q1 2021
- New holders
- 10
- 2 more added
- Sold out
- 14
- 22 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 1,341,663 | $6.67M | 1.44% | +1,341,663 | New |
| Vanguard Group Inc | 273,656 | $1.36M | 0.00% | −52,662−16.1% | Reduced |
| Geode Capital Management, LLC | 148,059 | $735.0K | 0.00% | −146,180−49.7% | Reduced |
| BlackRock Inc. | 142,422 | $707.0K | 0.00% | −820,106−85.2% | Reduced |
| Millennium Management LLC | 116,666 | $580.0K | 0.00% | +116,666 | New |
| Dimensional Fund Advisors LP | 80,825 | $402.0K | 0.00% | −4,096−4.8% | Reduced |
| Virtu Financial LLC | 68,007 | $338.0K | 0.03% | +68,007 | New |
| Truist Financial Corp | 59,660 | $297.0K | 0.00% | +59,660 | New |
| Ergoteles LLC | 47,984 | $238.0K | 0.01% | +47,984 | New |
| United Capital Financial Advisers, LLC | 47,691 | $237.0K | 0.00% | −23,600−33.1% | Reduced |
| Goldman Sachs Group Inc | 42,468 | $211.0K | 0.00% | −12,954−23.4% | Reduced |
| Tibra Equities Europe Ltd | 41,900 | $208.0K | 0.06% | +41,900 | New |
| HRT Financial LP | 41,058 | $204.0K | 0.00% | −41,578−50.3% | Reduced |
| First Trust Advisors LP | 37,618 | $187.0K | 0.00% | −1,317−3.4% | Reduced |
| State Street Corp | 32,791 | $163.0K | 0.00% | −155,381−82.6% | Reduced |
| Northern Trust Corp | 28,103 | $140.0K | 0.00% | −122,676−81.4% | Reduced |
| Parametric Portfolio Associates LLC | 21,787 | $108.0K | 0.00% | +3,424+18.6% | Added |
| Morgan Stanley | 18,987 | $93.0K | 0.00% | −146−0.8% | Reduced |
| Susquehanna International Group, LLP | 18,127 | $90.0K | 0.00% | +18,127 | New |
| ETF Managers Group, LLC | 14,099 | $72.0K | 0.00% | −220−1.5% | Reduced |
| Jane Street Group, LLC | 11,948 | $59.0K | 0.00% | +11,948 | New |
| Bank of New York Mellon Corp | 11,377 | $57.0K | 0.00% | −40,638−78.1% | Reduced |
| Royal Bank of Canada | 4,401 | $22.0K | 0.00% | +3,311+303.8% | Added |
| Jacobi Capital Management LLC | 4,500 | $22.0K | 0.00% | +4,500 | New |
| Barclays PLC | 3,908 | $20.0K | 0.00% | −16,572−80.9% | Reduced |
| BNP Paribas Arbitrage, SA | 3,285 | $16.3K | 0.00% | −2,272−40.9% | Reduced |
| Bank of America Corp | 2,702 | $13.0K | 0.00% | −28,413−91.3% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 2,250 | $11.0K | 0.00% | 00.0% | Unchanged |
| Meeder Asset Management Inc | 574 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 209 | $1.00K | 0.00% | −43,597−99.5% | Reduced |
| UBS Group AG | 260 | $1.00K | 0.00% | −3,291−92.7% | Reduced |
| TD Private Client Wealth LLC | 125 | $621 | 0.00% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 96 | $0 | 0.00% | −8,404−98.9% | Reduced |
| Wells Fargo & Company | 95 | $0 | 0.00% | −4,698−98.0% | Reduced |
| Citigroup Inc | 53 | $0 | 0.00% | −862−94.2% | Reduced |
| Ellis Investment Partners, LLC | 100 | $0 | 0.00% | −400−80.0% | Reduced |
| Cutler Group LP | 100 | $0 | 0.00% | +100 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −37,563−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −34,578−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −29,338−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −27,900−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −23,991−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −21,280−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −19,512−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −15,032−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −8,782−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −8,039−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,249−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,096−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −389−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −355−100.0% | Sold out |